Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Reviews of Infectious Diseases

• Publication date

  1983-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CLINIDS/5.4.748PMID 6622889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Summary of clinical trials of inactivated influenza vaccine - 1978.

  1983cited by this paper
• Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976.

  1979cited by this paper
• The Russian flu. Its history and implications for this year's influenza season.

  1978cited by this paper
• An unusual influenza situation in 1977-78.

  1978cited by this paper
• Comparative antigenicity and immunogenicity of 1976 influenza virus vaccines: results of mouse protection experiments.

  1978cited by this paper
• Evaluation and control of vaccines for the National Influenza Immunization Program.

  1977cited by this paper
• Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines.

  1977cited by this paper
• Summary of clinical trials of influenza virus vaccines in adults.

  1977cited by this paper
• Overview of clinical trials of influenza vaccines, 1976.

  1977cited by this paper
• Serologic responses to split and whole swine influenza virus vaccines in light of the next influenza pandemic.

  1977cited by this paper
• Reactogenicity and immunogenicity of bivalent influenza vaccine in one- and two-dose trials in children: a summary.

  1977cited by this paper
• Potentiation of the immune response to influenza virus subunit vaccines.

  1977cited by this paper
• Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines.

  1977cited by this paper
• Influenza at Christ's Hospital: March, 1974.

  1976cited by this paper
• Viral Infections of Humans

  1976cited by this paper
• Excess mortality from epidemic influenza, 1957-1966.

  1974cited by this paper
• CONTROL OF INFLUENZA

  1973cited by this paper
• Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren.

  1970cited by this paper
• Hong Kong influenza: the epidemiologic features of a high school family study analyzed and compared with a similar study during the 1957 Asian influenza epidemic.

  1970cited by this paper
• Immunization Against Influenza: Prevention of Illness in Man by Aerosolized Inactivated Vaccine

  1969cited by this paper
• Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine.

  1969cited by this paper
• DISQUISITIONS ON ORIGINAL ANTIGENIC SIN

  1966cited by this paper
• Immunization Against Influenza.

  1946cited by this paper

• The CombE-IDMS Assay as an Alternate Potency Method for Adjuvanted Quadrivalent Influenza Vaccines.

  2023cites this paper
• 31 – Inactivated Influenza Vaccines

  2018cites this paper
• Influenza A virus vaccines for swine.

  2017cites this paper
• Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies

  2017cites this paper
• Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines

  2017cites this paper
• Recombinant Hemagglutinin Subunit Vaccine Produced in a Baculovirus

  2016cites this paper
• Technical guidelines for the application of seasonal influenza vaccine in China (2014–2015)

  2015cites this paper
• Conformationally selective biophysical assay for influenza vaccine potency determination.

  2015cites this paper
• A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines

  2014cites this paper
• BRITISH BIOMEDICAL BULLETIN

  2014cites this paper
• Reincarnations of Influenza Virus and Challenges with the Development of a Robust Influenza Vaccine

  2014cites this paper
• New vaccines against influenza virus

  2013cites this paper
• 2012 Antigen Review for the New Zealand National Immunisation Schedule: Influenza

  2013cites this paper
• 17 – Inactivated influenza vaccines

  2013cites this paper
• Recent Advances in the Management of Viral Flu Infections

  2013cites this paper
• Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza

  2011cites this paper
• Influenza viral neuraminidase: the forgotten antigen

  2011cites this paper
• Novel vaccines against influenza viruses.

  2011cites this paper
• Immunobiological properties of Yersinia pestis antigens

  2011cites this paper
• Yersinia pestis with Regulated Delayed Attenuation as a Vaccine Candidate To Induce Protective Immunity against Plague

  2010cites this paper
• Vaccines for preventing influenza in the elderly.

  2010cites this paper
• Vaccines for preventing influenza in the elderly.

  2010cites this paper
• Seasonal influenza vaccines.

  2009cites this paper
• Development of an influenza virus vaccine using the baculovirus-insect cell expression system : implications for pandemic preparedness

  2009influential citation
• A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.

  2009cites this paper
• Human Dendritic Cell-Specific Intercellular Adhesion Molecule-Grabbing Nonintegrin (CD209) Is a Receptor for Yersinia pestis That Promotes Phagocytosis by Dendritic Cells

  2008cites this paper
• Plasminogen Activator Pla of Yersinia pestis Utilizes Murine DEC-205 (CD205) as a Receptor to Promote Dissemination*

  2008cites this paper
• Vaccines for preventing influenza in the elderly.

  2006cites this paper
• Reduced-Dose Influenza Vaccine

  2006cites this paper
• Calcium-Regulated Type III Secretion of Yop Proteins by an Escherichia coli hha Mutant Carrying a Yersinia pestis pCD1 Virulence Plasmid

  2006cites this paper
• Rapid Licensure of a New, Inactivated Influenza Vaccine in the United States

  2005cites this paper
• Cell-based protein vaccines for influenza.

  2005cites this paper
• Trivalent Influenza Vaccine Including NPhilippines (H3N2): Results of a Field Trial

  2005cites this paper
• Intraspecific Diversity of Yersinia pestis

  2004cites this paper
• Detection of cross-reacting epitopes on plasmid-encoded outer membrane proteins of enteropathogenic Yersinia by monoclonal antibodies

  2004cites this paper
• Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults.

  2002cites this paper
• Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

  2001cites this paper
• Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy.

  2001cites this paper
• Decreased antibody response among nursing home residents who received recalled influenza vaccine and results of revaccination, 1996-97.

  2000cites this paper
• Immunological Correlates for Efficacy of Combination Vaccines

  1999cites this paper
• Respiratory viral infections in the elderly

  1999cites this paper
• Influenza vaccines: present and future.

  1999cites this paper
• Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness.

  1997cites this paper
• The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age.

  1996cites this paper
• Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

  1996cites this paper
• Comparative detection of measles-specific IgM in oral fluid and serum from children by an antibody-capture IgM EIA.

  1996cites this paper
• Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults.

  1995cites this paper
• Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity.

  1994cites this paper
• Increased immunogenicity of inactivated influenza virus vaccine containing purified surface antigen compared with whole virus in elderly women

  1994cites this paper
• Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1.

  1994cites this paper
• Viral infections of the respiratory tract: prevention and treatment.

  1994influential citation
• Prevention and control of influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  1994cites this paper
• Prevention and control of influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  1993cites this paper
• Virulence factors of bacteria pathogenic for coldwater fish

  1993cites this paper
• Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature.

  1993cites this paper
• Influenza immunization in children with chronic arthritis: a prospective study.

  1993cites this paper
• Phenotypic modulation by Legionella pneumophila upon infection of macrophages

  1993cites this paper
• Prevalence of antibody to current influenza virus strains in a 1992 Canadian serosurvey and crude estimates of 1991-92 season A/Beijing/353/89 infections.

  1993cites this paper
• Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers.

  1993cites this paper
• Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines.

  1993cites this paper
• The difference in the lcrV sequences between Y. pestis and Y. pseudotuberculosis and its application for characterization of Y. pseudotuberculosis strains.

  1992cites this paper
• Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989.

  1991cites this paper
• Comparison of adverse reactions to whole-virion and split-virion influenza vaccines in hospital personnel.

  1991cites this paper
• Influenza immunization: intranasal live vaccinia recombinant contrasted with parenteral inactivated vaccine.

  1991cites this paper
• Influenza Vaccines and the Wyeth-Ayerst Experience with Syntex Adjuvant

  1991cites this paper
• [Perimyocarditis in influenza A virus infection].

  1991cites this paper
• Perimyokarditis bei Influenza A Virus-Infektion

  1991cites this paper
• Antibody response to inactivated influenza vaccines of various antigenic concentrations.

  1990cites this paper
• Prophylaxis and treatment of influenza.

  1990cites this paper
• [Postvaccinal anti-influenza immunity and its determining factors].

  1990cites this paper
• Structural basis of immune recognition of influenza virus hemagglutinin.

  1990cites this paper
• Molecular analysis of lcrGVH, the V antigen operon of Yersinia pestis

  1989cites this paper
• Immunization of Elderly People with High Doses of Influenza Vaccine

  1988cites this paper
• Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines

  1988cites this paper
• Regulation of hemolysin expression in Actinobacillus pleuropneumoniae serotype 1 by Ca2+

  1988cites this paper
• Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation.

  1988cites this paper
• The virulence protein Yop5 of Yersinia pseudotuberculosis is regulated at transcriptional level by plasmid‐plB1 ‐encoded trans‐acting elements controlled by temperature and calcium

  1988cites this paper
• The Control of Influenza

  1987cites this paper
• Molecular cloning and expression of calcium-regulated, plasmid-coded proteins of Y. pseudotuberculosis.

  1987cites this paper
• Comparison of one- and two-dose regimens of influenza vaccine for elderly men.

  1987cites this paper
• Probing the phagolysosomal environment of human macrophages with a Ca2+-responsive operon fusion in Yersinia pestis

  1986cites this paper
• Monoclonal antibodies directed against plasmid-encoded released proteins of enteropathogenic Yersinia

  1986cites this paper
• A low-Ca2+ response operon encodes the V antigen of Yersinia pestis

  1986cites this paper
• Immunogenicity of a single dose of trivalent influenza vaccine including A/Philippines (H3N2): Results of a field trial

  1986cites this paper
• Role of a plasmid in the pathogenicity of Yersinia species.

  1985cites this paper
• Biotest zum Nachweis von Hydroxamat‐Fe‐Chelatoren (Aerobactin)

  1985cites this paper
• Immune response to plasmid- and chromosome-encoded Yersinia antigens

  1985cites this paper
• Inhibition of human neutrophil chemiluminescence by plasmid-mediated outer membrane proteins of Yersinia enterocolitica

  1985cites this paper
• Genetically manipulated virulence of Yersinia enterocolitica

  1984cites this paper
• In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae

  1984cites this paper
• Summary of clinical trials of inactivated influenza vaccine - 1978.

  1983cites this paper
• Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety.

  1983cites this paper